I agree. I don't think they intentionally didn't
Post# of 148293
Samsung obviously wants CytoDyn to be successful, so I expect them to infuse cash as some point if some deal is not inked soon. IMO there is no question that they will get Leronlimab to market no later than end of 1Q2020, the questions that remain are at what costs to current shareholders and how what road we travel on to get there (dangerous mountain road, interstate or somewhere in the middle)?